Large Payers, Including CMS, PBMs, Mostly Absent From PCORI Board
Executive Summary
With some very overt participation in comparative effectiveness research, one may have expected representatives from traditional large health care organizations or pharmacy benefit managers to be appointed to the Patient-Centered Outcomes Research Institute first board of governors. However, they were left off the board, announced Sept. 23.
You may also be interested in...
Former CMS Officials Call For Cost To Be Factored Into Coverage Decisions
Four former CMS officials are recommending authority to use cost-related analysis and policies be added to the tools the agency can use as a means of improving the quality and efficiency of Medicare.
Former CMS Officials Call For Cost To Be Factored Into Coverage Decisions
Four former CMS officials are recommending authority to use cost-related analysis and policies be added to the tools the agency can use as a means of improving the quality and efficiency of Medicare.
Academia Dominates Appointments To PCORI Methodology Committee
Pharma industry execs nominated by Personalized Medicine Coalition fail to get seats on the committee that will set methodological standards for research conducted through the Patient-Centered Outcomes Research Institute.